-
$0
0.0% of portfolio
-
Q1 2024
Added 1.38%
$7.71B
$23 Million
0.0% of portfolio
1,100,000
Q3 2020
Reduced 87.36%
$5.07B
$18.5 Million
0.0% of portfolio
194,682
Q4 2023
New
$8.43B
$27.2 Million
0.0% of portfolio
1,550,118
Q1 2024
Added 0.13%
$13B
$0
0.0% of portfolio
-
Q1 2024
New
$7.53B
$1.74 Million
0.0% of portfolio
229,524
Q4 2018
Reduced 95.45%
$35.9M
$2.8 Million
0.0% of portfolio
779,368
Q2 2022
Added 0.04%
$51.5B
$360,000
0.0% of portfolio
9,766
Q4 2023
New
$0
$6.97 Million
0.0% of portfolio
13,327
Q1 2024
Reduced 13.09%
$629M
$1.72 Million
0.0% of portfolio
1,043,695
Q3 2019
Reduced 4.85%
$5.91B
$4.38 Million
0.0% of portfolio
57,659
Q1 2022
New
-
$0
0.0% of portfolio
-
Q3 2023
New
$14.8B
$752,000
0.0% of portfolio
18,350
Q1 2024
Added 0.82%
$8.02B
$27 Million
0.0% of portfolio
42,000
Q1 2022
Reduced 83.44%
$22.1B
$2.29 Million
0.0% of portfolio
143,106
Q1 2024
Added 7.78%
$18.7B
$387,000
0.0% of portfolio
9,801
Q4 2023
Added 44.99%
Canadian Pacific Kansas City
-
$0
0.0% of portfolio
-
Q1 2024
Added 0.12%
$18.2B
$3.36 Million
0.0% of portfolio
35,000
Q1 2024
Reduced 95.51%
$79.9B
$992,000
0.0% of portfolio
7,536
Q4 2023
Added 26.53%
$107M
$17.4 Million
0.0% of portfolio
8,707,600
Q1 2024
Added 1.49%
$28.7B
$1.06 Million
0.0% of portfolio
19,432
Q4 2023
Added 14.48%
Structure Therapeutics Inc
-
$0
0.0% of portfolio
-
Q4 2023
Added 531.63%
$1.56B
$5.35 Million
0.0% of portfolio
392,012
Q3 2023
Reduced 56.92%
$99.6M
$3.91 Million
0.0% of portfolio
2,056,000
Q4 2023
Reduced 49.88%
$2.61B
$19 Million
0.0% of portfolio
204,315
Q1 2024
Reduced 48.97%
$1.16B
$9.18 Million
0.0% of portfolio
340,000
Q2 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
Added 3.95%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 4.32%
$38.1B
$24.8 Million
0.0% of portfolio
430,715
Q1 2024
Reduced 93.91%
$229B
$2.11 Million
0.0% of portfolio
10,819
Q1 2024
Reduced 48.94%
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q3 2023
Added 134.96%
$1.46B
$20.6 Million
0.0% of portfolio
1,063,800
Q1 2023
New
$5.32B
$22.7 Million
0.0% of portfolio
430,000
Q2 2021
Reduced 0.01%
$0
$19.9 Million
0.0% of portfolio
216,797
Q1 2024
Reduced 0.33%
$2.01B
$27.6 Million
0.0% of portfolio
530,786
Q1 2024
Reduced 52.4%
$3.88B
$16.8 Million
0.0% of portfolio
305,059
Q4 2020
New
$15B
$2.71 Million
0.0% of portfolio
89,776
Q1 2024
Added 6.6%
$100B
$2.43 Million
0.0% of portfolio
91,983
Q1 2024
Added 1.46%
$12.5B
$1.32 Million
0.0% of portfolio
110,678
Q4 2023
Reduced 87.38%
$315M
$12.7 Million
0.0% of portfolio
3,390,000
Q1 2021
Reduced 37.75%
$35B
$4.75 Million
0.0% of portfolio
283,581
Q1 2024
Reduced 45.32%
-
$0
0.0% of portfolio
-
Q1 2024
Added 16.82%
$6.92B
$18.7 Million
0.0% of portfolio
150,000
Q1 2021
Reduced 80.27%
$390M
$21.2 Million
0.0% of portfolio
754,805
Q3 2023
Added 4.82%
$32.1B
$7.37 Million
0.0% of portfolio
34,200
Q4 2023
New
$125M
$838,000
0.0% of portfolio
401,284
Q4 2020
Reduced 13.93%
$414M
$607,000
0.0% of portfolio
73,395
Q2 2021
Reduced 22.66%
$54.6B
$315,000
0.0% of portfolio
6,099
Q4 2023
Added 1.28%
$57.2B
$952,000
0.0% of portfolio
9,749
Q3 2023
Added 1.33%